A LIGHTning Strike to the Metastatic Niche

Amaia Martinez-Usatorre1, Michele De Palma1

  • 1Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.

Cell Reports
|January 23, 2020
PubMed

Insights

Targeting the cytokine LIGHT to lung blood vessels can stop cancer from spreading to the lungs. This research shows a new way to prevent lung metastasis in mice.

Area of Science:

  • Oncology
  • Immunology
  • Vascular Biology

Background:

  • Tumor-induced changes in distant organ vasculature are implicated in cancer metastasis.
  • The lung is a common site for metastasis from various primary cancers.

Purpose of the Study:

  • To investigate the role of the cytokine LIGHT in the context of lung metastasis.
  • To determine if targeting LIGHT delivery to pulmonary vasculature can inhibit cancer spread to the lungs.

Main Methods:

  • Utilized a mouse model to study lung metastasis.
  • Administered the cytokine LIGHT to the pulmonary vasculature.
  • Assessed the establishment of lung metastases.

Main Results:

  • Targeting the cytokine LIGHT to the pulmonary vasculature effectively prevented lung metastasis formation in mice.
  • Demonstrated the therapeutic potential of LIGHT in controlling cancer spread.

Conclusions:

  • The cytokine LIGHT delivered to lung vasculature is a viable strategy to prevent lung metastasis.
  • Findings suggest novel therapeutic avenues for managing metastatic cancer.